New pill aims to fight narcolepsy sleepiness
Symptom relief
Not yet recruiting
This study tests an experimental drug called E2086 in 64 adults with narcolepsy to see if it reduces excessive daytime sleepiness and cataplexy (sudden muscle weakness). Participants will receive either E2086 or a placebo for 4 weeks. The main goal is to measure how well they can…
Phase: PHASE2 • Sponsor: Eisai Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC